Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1996
11/12/1996US5574060 Selective inhibitors of biogenic amine transporters
11/12/1996US5574048 Methods of inhibiting hirsutism and alopecia in women
11/12/1996US5574047 Methods of inhibiting imperfect tissue repair
11/12/1996US5574039 Antitumor, fungicides
11/12/1996US5574036 Adamantyl-substituted polycyclic acetylene compounds and pharmaceutical/cosmetic compositions comprised thereof
11/12/1996US5574035 S-timolol hemihydrate composition and method of preparation therefor
11/12/1996US5573781 Injectable fatty acid ester and cytostatic agent
11/12/1996CA2105302C 1-azabicyclo¬3.2.2.|nonan-3-amine derivatives
11/12/1996CA2068438C Essential pure human parathyroid hormone
11/12/1996CA2040319C Sulfonylamino substituted bicyclyl hydroxamic acid derivatives
11/10/1996CA2175881A1 Vitamin d compounds and methods of preparing these compounds
11/08/1996EP0748793A4 Ketopanthenol with acetylating properties
11/07/1996WO1996034969A2 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034885A2 Biologically active peptide fragments of ob protein
11/07/1996WO1996034881A1 Peptide compositions with growth factor-like activity
11/07/1996WO1996034867A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/07/1996WO1996034866A1 Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034863A1 Novel heterocyclic chemistry
11/07/1996WO1996034857A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034852A1 Novel tetracycline derivatives
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996WO1996034525A1 Inducement of thermotolerance with benzoquinonoid ansamycins
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2219277A1 Novel tetracycline derivatives
11/07/1996CA2218523A1 Inducement of thermotolerance with benzoquinonoid ansamycins
11/07/1996CA2218390A1 Gene therapy using replication competent targeted adenoviral vectors
11/06/1996EP0741139A1 Sulphuric acid esters of amino sugars
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0741128A2 Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls
11/06/1996EP0740940A2 Process for disinfecting musculoskeletal tissue and tissues prepared thereby
11/06/1996EP0740938A2 Proline and 4-hydroxyproline as therapeutic agents
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740936A2 Use of benzopyran derivatives for the manufacture of medicaments for the treatment of diseases connected with the sodium independent Cl-/HCO3- exchanger
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740668A1 Tetracyclic derivatives, process of preparation and use
11/06/1996EP0740658A1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
11/06/1996EP0740655A1 Metalloproteinase inhibitors
11/06/1996EP0740654A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0740652A1 Metalloproteinase inhibitors
11/06/1996EP0740551A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
11/06/1996EP0675712A4 Reduction of hair growth employing sulfhydryl reactive compounds.
11/06/1996CN1135218A Piperidine derivatives
11/06/1996CN1135178A Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or doner, or a nitric oxide inhibitor
11/06/1996CN1135176A Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio-and post menopausal women
11/06/1996CN1134938A Novel alkylated (hetero) cyclic compounds, process for their prepn. and pharmaceutical compositions contg. same
11/06/1996CA2175786A1 Igf-1 superagonists
11/06/1996CA2175747A1 Benzopyrane derivatives used for preparing pharmaceutical compositions used in the treatment of pathology related to na+ independent cl-/hco3- exchanger
11/06/1996CA2174583A1 Sulfuric acid esters of sugar alcohols
11/06/1996CA2174582A1 Sulphuric acid esters of amino-sugars
11/05/1996US5571942 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
11/05/1996US5571925 Angiotensin II antagonists
11/05/1996US5571918 Reacting 3-hydroxy-3-mercaptomethylquinuclidine and a carbonyl compound in the presence of a catalyst
11/05/1996US5571845 Nitroaniline derivatives and their use as anti-tumour agents
11/05/1996US5571835 Inhibitors of farnesyl-protein transferase
11/05/1996US5571834 Pharmaceutical composition useful for the treatment of cardiovascular diseases
11/05/1996US5571826 Heterocyclic compounds and their preparation and use
11/05/1996US5571813 Treatment of hypertension, congestive heart failure, renal failure
11/05/1996US5571808 Substituted 2-aryl-3-aroylbenzo(b)thiophenes
11/05/1996US5571802 Method of treating post menopausal osteoporosis with hexafluro-vitamin D
11/05/1996US5571798 Synergistic antiviral nucleoside combinations
11/05/1996US5571792 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
11/05/1996US5571186 Porous hydroxyapatite or tricalcium phosphate, 7-isopropoxyisoflavone
10/1996
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996WO1996034010A2 Inhibitors of farnesyl-protein transferase
10/31/1996WO1996033993A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/31/1996WO1996033985A1 Piperidine derivatives as diuretic
10/31/1996WO1996033981A1 Quinazoline derivative
10/31/1996WO1996033980A1 Quinazoline derivatives
10/31/1996WO1996033979A1 Quinazoline derivatives
10/31/1996WO1996033978A1 Quinazoline derivative
10/31/1996WO1996033977A1 Quinazoline derivatives
10/31/1996WO1996033735A1 Human antibodies derived from immunized xenomice
10/31/1996WO1996033716A1 RARβ SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY
10/31/1996WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996WO1996033701A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
10/31/1996WO1996027384A3 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase
10/31/1996DE19515275A1 Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe) New use of (S) -Adenosyl-L-methionine (SAMe)
10/31/1996CA2761116A1 Human antibodies derived from immunized xenomice
10/31/1996CA2219261A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/31/1996CA2219028A1 Rar.beta. selective retinoid compounds for inhibiting gene expression promoted by ap1 protein and their use in therapy
10/31/1996CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/30/1996EP0739898A2 Phosphonomonoester nucleic acids, methods for their preparation and their use
10/30/1996EP0739892A2 Chromone derivatives
10/30/1996EP0739891A2 Substituted heterocycles
10/30/1996EP0739886A2 Selective thrombin inhibitors
10/30/1996EP0739881A2 Piperidine derivatives
10/30/1996EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
10/30/1996EP0739351A1 Monomeric diols and phosphate linked oligomers formed therefrom
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739343A1 Water soluble onium salt of taxo-diterpenoid
10/30/1996EP0739340A1 Phenyl heterocycles as cox-2 inhibitors
10/30/1996EP0739338A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
10/30/1996EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists
1 ... 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 ... 1564